Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 45
B
Registered Attendees
Neha Agarwal Lisheng Cai
University of California–Berkeley National Institute of Mental
Health
Chiiko Asanuma
Marc Cantillon
National Institute of Mental
Health Coalition Against Major Disease,
Critical Path
Helene Benveniste
Juan Chavez
University Medical Center at Stony
Brook Regeneron Pharmaceuticals
Lizbet Boroughs William Cho
American Psychiatric Association Merck and Co., Inc.
Linda Brady Alice Luo Clayton
National Institute of Mental Health Journalist
Health
Vlad Coric
Robbin Brodbeck Bristol-Myers Squibb
Lundbeck Research USA
Alan Cross
Neil Buckholtz AstraZeneca Pharmaceuticals
National Institute on Aging
Jasbeer Dhawan
Brookhaven National Laboratory
45
OCR for page 46
46 GLUTAMATE-RELATED BIOMARKERS IN DRUG DEVELOPMENT
Dario Doller Frederick Knox
Lundbeck Research USA United States Navy (Retired)
Jamie Driscoll Jaya Kolli
National Institute of Mental Ross University School of Medicine
Health
David Lee
Melissa Dupree Foundation for NIH
Fabiani & Company
Serguei Liachenko
Katherine Falk National Center for Toxicology
Mt. Sinai School of Medicine Research
Gwenaelee Fillon Johan Luthman
Hoffman-La Roche, Inc. Merck and Co., Inc.
Jarlath French-Mullen Ronald Marcus
GeneLogic/Ocimum Biosolutions Bristol-Myers Squibb
Robert Gibbons Michael Marino
University of Illinois–Chicago Merck and Co., Inc.
Sarah Grimwood Shawnmarie Mayrand-Ching
Pfizer Inc. National Institutes of Health
Michele Hindi-Alexander Diana Morales
National Institutes of Health National Institutes of Health
Garry Honey Laurie Nadler
Pfizer Inc. National Institute of Mental
Health
Thomas Insel
Richard Nakamura
National Institute of Mental
Health National Institute of Mental
Health
Carrie Jones
Lindsay Pascal
Vanderbilt University
AAAS
John Kehne
Victor Pike
Translational Neuropharmacology
Consulting, LLC National Institute of Mental
Health
OCR for page 47
47
APPENDIX B
Jorge Quiroz Cristina Tan Hehir
Hoffman-La Roche, Inc. GE Global Research
Jean Rifkin Pam Tannenbaum
Diabetes Seminars Merck and Co., Inc.
Erica Rosemond Christian Thomsen
National Institute of Mental Lundbeck Research USA
Health
Dan van Kammen
Deborah Runkle CHDI Foundation
AAAS
Philip Wang
Judy Siuciak National Institute of Mental
Foundation at NIH Health
Renuka Sriram Lois Winsky
Pfizer Inc. National Institute of Mental
Health
Thomas Steckler
Frank Yocca
Johnson & Johnson
AstraZeneca Pharmaceuticals
Cyrille Sur
Huailing Zhong
Merck and Co., Inc.
Lundbeck Research USA
OCR for page 48
